期刊文献+

应用McMSP分析Rassfla启动子区域甲基化

Analysis Rassfla Methylation Patterns by McMSP
下载PDF
导出
摘要 目的应用McMSP分析抑癌基因Rassfla启动子区域甲基化,同时比较MSP与McMSP之间的异同。方法(1)对常规甲基特异性PCR(MSP)扩增后的产物进行熔解曲线分析(MCA);(2)将SYBRGreenⅠ直接加入PCR反应前体系进行扩增;(3)探索McMSP分析的灵敏度,将标本按1:10、1:100、1:500、1:1000、1:5000、1:10000稀释后,分别行MSP和McMSP。结果(1)不应用商业试剂盒同时将SYBRGreenⅠ浓度降低,仍能获得较好结果;(2)Q—PCRMCA能将完全甲基化和完全未甲基化DNA标本区分;(3)在将DNA标本1:10000稀释后(DNA量〈2pg)仍可以检测到所需要的目的产物,而常规MSP在1:100稀释(DNA量〉100pg)时就已不能检测到产物;(4)McMSP区分正常癌旁组织和癌组织的能力较常规MSP大大增强。结论利用Q—PCRMCA分析Rassfla启动子区域甲基化迅速准确,操作简便,结果以曲线形式给出,具有较常规MSP更高的灵敏度和区分能力。 Objects Detect TSG Rassfla promoter region methylation pattern based on Q-PCR, and compare McMSP and MSP.Methods Firstly,run MCA to the MSP products;secondly,add SYBR Green Ⅰ to the pre-PCR mix; Finally, dilute the original DNA templates and compare the sensitivity between MSP and McMSP.Results (1)The results are satisfied even without commercial kits and lower SYBR Green I concentration; (2)McMSP can distinguish the samples which are fully methylated and fully unmethylated; (3)Q-PCR can perform perfectly even the original (DNA templates 〈 2pg),while,MSP become introducible even the original (DNA templates 〉 100pg); (4) MeMSP can distinguish normal and cancer tissue more efficiently than MSP. Conclusions Analyzing TSG promoter region methylation pattern by Q-PCR MCA is quick, sensitive and advantage, as well as its better distinguish ability.
出处 《国际医药卫生导报》 2009年第6期81-83,共3页 International Medicine and Health Guidance News
关键词 实时荧光定量PCR 熔解曲线分析 DNA甲基化 SYBR Green McMSP Melting curve analysis DNA methylation SYBR Green Ⅰ
  • 相关文献

参考文献7

  • 1Dahl C, Guldberg P. DNA methylation analysis techniques [J].Biogerontology. 2003,4(4):233-250.
  • 2Agathanggelou A, Cooper WN, atif F. Role of the Ras-association domain family 1 tumor suppressor gene in human cancers [J].Cancer Res. 2005, 65(9):497-508.
  • 3张剑英,李智.RASSF1基因与肿瘤的关系[J].国外医学(临床生物化学与检验学分册),2005,26(2):120-122. 被引量:7
  • 4Chan MW, Chu ES, To KF, et al. Quantitative detection of methylated SOCS-I,a tumor suppressor gene, by a modified protocol of quantitative real time methylation-specific PCR using SYBR green and its use in early gastric cancer detection [J].Biotechnology Letters. 2004,26(16):1289-1293.
  • 5Akey DT, Akey JM, Zhang K, et al. Assaying DNA methylation based on high-throughput melting curve approaches [J].Genomics. 2002,80(4):376-384.
  • 6Burbee DG, Forgacs E, Zochbauer-Muller S, et al. Epigenetic inactivation of RASSF1A in lung and breast cancersand malignant phenotype suppression [J].J Natl Cancer Inst, 2001,93(9):691-699.
  • 7Smith E, Bianco-Miotto T, Drew P, et al. Method for optimizing methylation-specific PCR [J]. Biotechniques. 2003,35(1):32-33.

二级参考文献15

  • 1Dammann R, Li C, Yoon JH, et al. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet, 2000, 25(3): 315-319.
  • 2Ortiz-Vega S, Khokhlatchev A, Nedwidek M, et al. The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1. Oncogene, 2002, 21(9): 1381-1390.
  • 3Dreijerink K, Braga E, Kuzmin I, et al. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc Natl Acad Sci USA, 2001, 98(13): 7504-7509.
  • 4Shivakumar L, Minna J, Sakamaki T, et al. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol, 2002, 22(12): 4309-4318.
  • 5Tomizawa Y, Kohno T, Kondo H, et al. Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma. Clin Cancer Res, 2002, 8(7): 2362-2368.
  • 6Agathanggelou A, Honorio S, Macartney DP, et al. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene, 2001, 20(12): 1509-1518.
  • 7Zhang YJ, Ahsan H, Chen Y, et al. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Mol Carcinog, 2002, 35(2): 85-92.
  • 8Byun DS, Lee MG, Chae KS, et al. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma. Cancer Res, 2001, 61(19): 7034-7038.
  • 9van-Engeland M, Roemen GM, Brink M, et al. K-ras mutations and RASSF1A promoter methylation in colorectal cancer. Oncogene, 2002, 21(23): 3792-3795.
  • 10Dammann R, Schagdarsurengin U, Liu L, et al. Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma. Oncogene, 2003, 22(24): 3806-3812.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部